AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
231.50
+4.00 (1.76%)
At close: Feb 13, 2026, 4:00 PM EST
232.30
+0.80 (0.35%)
After-hours: Feb 13, 2026, 7:58 PM EST
AbbVie Stock Forecast
Stock Price Forecast
The 16 analysts that cover AbbVie stock have a consensus rating of "Buy" and an average price target of $243.88, which forecasts a 5.35% increase in the stock price over the next year. The lowest target is $194 and the highest is $289.
Price Target: $243.88 (+5.35%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 3 | 4 | 4 | 3 |
| Buy | 12 | 12 | 11 | 9 | 9 | 8 |
| Hold | 5 | 5 | 6 | 5 | 7 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 22 | 20 | 18 | 20 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $240 → $230 | Hold | Maintains | $240 → $230 | -0.65% | Feb 5, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $232 → $228 | Buy | Maintains | $232 → $228 | -1.51% | Feb 5, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $269 → $270 | Buy | Maintains | $269 → $270 | +16.63% | Feb 5, 2026 |
| Citigroup | Citigroup | Hold Maintains $235 → $230 | Hold | Maintains | $235 → $230 | -0.65% | Jan 27, 2026 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 8, 2026 |
Financial Forecast
Revenue This Year
68.30B
from 61.16B
Increased by 11.68%
Revenue Next Year
73.67B
from 68.30B
Increased by 7.86%
EPS This Year
14.52
from 2.36
Increased by 515.33%
EPS Next Year
16.25
from 14.52
Increased by 11.91%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 71.5B | 78.0B | |||
| Avg | 68.3B | 73.7B | |||
| Low | 63.7B | 67.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 16.9% | 14.1% | |||
| Avg | 11.7% | 7.9% | |||
| Low | 4.2% | -1.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.80 | 18.30 | |||
| Avg | 14.52 | 16.25 | |||
| Low | 12.99 | 14.29 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 569.6% | 26.0% | |||
| Avg | 515.3% | 11.9% | |||
| Low | 450.6% | -1.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.